CAJ | 학술논문

目的：探讨肝细胞癌合并门静脉癌栓手术治疗的安全性及效果。方法回顾2007年1月至2011年12月之间71例肝细胞癌合并门静脉癌栓患者,行手术切除加门静脉取栓术的病例资料,分析手术治疗安全性及效果。结果71例肝癌门静脉癌栓患者术后平均住院天数为25.2 d(11~60 d),平均手术时间230 min(95~420 min),平均失血量和输血量分别为740 ml(100~3500 ml)和420 ml (0~4600 ml),平均肝门阻断时间为8.7 min(0~35 min),术后的平均生存期为15.3个月,1年生存率为51.7%,2年生存率为34.5%,3年生存率为6.9%。全组术后发生并发症13例,均治愈,无围术期死亡患者。结论肝癌伴门静脉癌栓患者行肝癌切除和门静脉取栓是安全的,可明显延长患者的生存期。
목적：탐토간세포암합병문정맥암전수술치료적안전성급효과。방법회고2007년1월지2011년12월지간71례간세포암합병문정맥암전환자,행수술절제가문정맥취전술적병례자료,분석수술치료안전성급효과。결과71례간암문정맥암전환자술후평균주원천수위25.2 d(11~60 d),평균수술시간230 min(95~420 min),평균실혈량화수혈량분별위740 ml(100~3500 ml)화420 ml (0~4600 ml),평균간문조단시간위8.7 min(0~35 min),술후적평균생존기위15.3개월,1년생존솔위51.7%,2년생존솔위34.5%,3년생존솔위6.9%。전조술후발생병발증13례,균치유,무위술기사망환자。결론간암반문정맥암전환자행간암절제화문정맥취전시안전적,가명현연장환자적생존기。
Objective To study the prognosis of hepatic resection of portal vein tumor thrombus (PVTT)for hepatocellular carcinoma (HCC).Methods A total of 71 HCC patients with concurrent PVTT from January 2007 to December 201 1 underwent liver resection and removal of PVTT. Results The mean length of hospital stay was 25.2(1 1 -60)days,mean operative duration 230(95 -420)min,mean blood loss volume 740 (100-3 500)ml,blood transfusion volume 420(0-4 600)ml, mean hepatic vascular occlusion 8.7(0-35)min and mean survival time 1 5.3 months.And 1 ,2 and 3-year survival rates were 5 1 .7%, 34.5% and 6.9% respectively.Conclusions Hepatic resection with removal of PVTT for HCC is safe and it may elongate the patient survival and improve quality of life.